This is to inform that due to some circumstances beyond the organizer control, "3rd Edition of International Alzheimer's Disease & Dementia Conference" (Dementia 2025) June 05-07, 2025 | Hybrid Event has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at dementia@magnusconference.com or call + 1 (702) 988 2320.
Alzheimer's disease (AD) is a chronic neurological condition that is regarded as one of the most challenging medical problems to treat, with significant societal and economic consequences. The number of persons living with Alzheimer's disease (AD) in the United States is increasing. Drug discovery in stages of Alzheimer's disease before symptomatic dementia, such as preclinical AD, has resulted from significant research investment. There are now six phase 3 clinical trials for preclinical AD treatments, despite the fact that no medicines for preclinical AD have been approved.
Despite decades of preclinical research to better understand the disease and uncover treatment targets, Alzheimer's disease remains incurable. The challenge is being met with new methods of thinking about a number of animal models. Alzheimer's disease (AD) experimental models are essential for better understanding aetiology and evaluating the efficacy of innovative therapy approaches. Transgenic mice that overexpress human genes linked to familial Alzheimer's disease (FAD) and generate amyloid plaques are the most extensively utilized experimental animal models.
Important Alert:
X
Title : Early clinical development of modified P8 for the treatment of alzheimer’s disease
Nazneen N Dewji, Cenna Biosciences Inc, United States
Title : Who cares for the carers
Jacqueline Tuppen, Cogs Club, United Kingdom
Title : Memory should be the primary endpoint in early AD
Matthias W Riepe, Ulm University, Germany
Title : Down’s syndrome (trisomy 21) and alzheimer disease: A common medical and scientific fight
London Jacqueline, Paris Diderot University, France
Title : Quality of life children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Efficacy of transcranial photobiomodulation in mild cognitive impairment and early alzheimer’s Disease: A randomized controlled study
Hyelim Chun, St.Peter’s General Hospital, Korea, Republic of